Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12003)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 28, 2016 (publication date) through Jul 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Marks EI, Yee NS. Molecular genetics and targeted therapeutics in biliary tract carcinoma. World J Gastroenterol 2016; 22(4): 1335-1347 [PMID: 26819503 DOI: 10.3748/wjg.v22.i4.1335] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i4/1335.htm |
| Number | Citing Articles |
| 1 |
Feiling Feng, Qingbao Cheng, Liang Yang, Dadong Zhang, Shunlong Ji, Qiangzu Zhang, Yihui Lin, Fugen Li, Lei Xiong, Chen Liu, Xiaoqing Jiang. Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing. Oncotarget 2017; 8(3): 5349 doi: 10.18632/oncotarget.14146
|
| 2 |
Marie Uecker, Ulrich Lehmann, Peter Braubach, Nagoud Schukfeh, Omid Madadi-Sanjani, Benno M. Ure, Claus Petersen, Joachim F. Kuebler. Choledochal Cysts Resected during Childhood Show No Mutations of KRAS and BRAF as Early Markers of Malignancy in Cholangiocytes. European Journal of Pediatric Surgery 2021; 31(01): 020 doi: 10.1055/s-0040-1715610
|
| 3 |
Nelson S. Yee, Nikki P. Lee. Special Issue: Cancer Biomarkers and Targets in Digestive Organs. Biomedicines 2019; 7(1): 3 doi: 10.3390/biomedicines7010003
|
| 4 |
Caiyun Nie, Huifang Lv, Yishu Xing, Beibei Chen, Weifeng Xu, Jianzheng Wang, Xiaobing Chen. The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07907-4
|
| 5 |
Feiling Feng, Qingbao Cheng, Bin Li, Chen Liu, Huizhen Wang, Bin Li, Xiaoya Xu, Yong Yu, Zishuo Chen, Xiaobing Wu, Hua Dong, Kaijian Chu, Zhenghua Xie, Qingxiang Gao, Lei Xiong, Fugen Li, Bin Yi, Dadong Zhang, Xiaoqing Jiang. Establishment and characterization of 38 novel patient-derived primary cancer cell lines using multi-region sampling revealing intra-tumor heterogeneity of gallbladder carcinoma. Human Cell 2021; 34(3): 918 doi: 10.1007/s13577-021-00492-5
|
| 6 |
Zhikai Chi, Amarpreet Bhalla, Omer Saeed, Liang Cheng, Kendra Curless, Hanlin L. Wang, Deepa T. Patil, Jingmei Lin. Mucinous intrahepatic cholangiocarcinoma: a distinct variant. Human Pathology 2018; 78: 131 doi: 10.1016/j.humpath.2018.04.010
|
| 7 |
Nelson S. Yee, Eugene J. Lengerich, Kathryn H. Schmitz, Jennifer L. Maranki, Niraj J. Gusani, Leila Tchelebi, Heath B. Mackley, Karen L. Krok, Maria J. Baker, Claire de Boer, Julian D. Yee. Frontiers in Gastrointestinal Oncology: Advances in Multi-Disciplinary Patient Care. Biomedicines 2018; 6(2): 64 doi: 10.3390/biomedicines6020064
|
| 8 |
Chun-Nan Yeh, Chi-Wei Chang, Yi-Hsiu Chung, Shi-Wei Tien, Yong-Ren Chen, Tsung-Wen Chen, Ying-Cheng Huang, Hsin-Ell Wang, You-Cheng Chou, Ming-Huang Chen, Kun-Chun Chiang, Wen-Sheng Huang, Chung-Shan Yu. Synthesis and characterization of boron fenbufen and its F-18 labeled homolog for boron neutron capture therapy of COX-2 overexpressed cholangiocarcinoma. European Journal of Pharmaceutical Sciences 2017; 107: 217 doi: 10.1016/j.ejps.2017.07.019
|
| 9 |
Xiao Xiao, Jun Zhou, Meng Fang, Jun Ji, Chenjun Huang, Fei Du, Wenchao Ai, Ying Wang, Zhiyuang Gao, Zhiquan Qiu, Chunfang Gao. Quantitative detections of TP53 gene mutations improve the diagnosis and prognostic prediction of biliary tract cancers using droplet digital PCR. Journal of Clinical Laboratory Analysis 2022; 36(1) doi: 10.1002/jcla.24103
|
| 10 |
Chengxin He, Lei Duan, Huiru Zheng, Jesse Li-Ling, Linlin Song, Longhai Li. Graph convolutional network approach to discovering disease-related circRNA-miRNA-mRNA axes. Methods 2022; 198: 45 doi: 10.1016/j.ymeth.2021.10.006
|
| 11 |
SyedaIqra Usman, Zeeshan Nahid, Asfa Shams, Kafil Akhtar. Gallbladder adenocarcinoma with incidental finding of xanthogranulomatous cholecystitis and tubercular lymphadenitis: A rare case report. Gastroenterology, Hepatology and Endoscopy Practice 2022; 2(4): 169 doi: 10.4103/ghep.ghep_17_22
|
| 12 |
Paula Fluxá, Daniel Rojas-Sepúlveda, María Alejandra Gleisner, Andrés Tittarelli, Pablo Villegas, Loreto Tapia, María Teresa Rivera, Mercedes Natalia López, Felipe Catán, Mario Uribe, Flavio Salazar-Onfray. High CD8+ and absence of Foxp3+ T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4147-6
|
| 13 |
Sean Turbeville, Carl S. Hornfeldt, Milind Javle, Eric Tran, Marion Schwartz. Emerging therapies for the treatment of cholangiocarcinoma. International Journal of Hepatobiliary and Pancreatic Diseases 2017; 7(2): 36 doi: 10.5348/ijhpd-2017-72-RA-8
|
| 14 |
Yu Qiu, Chao Pu, Yanchao Li, Baochuang Qi. Construction of a circRNA-miRNA-mRNA network based on competitive endogenous RNA reveals the function of circRNAs in osteosarcoma. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-1134-1
|
| 15 |
Iris Tischoff, Andrea Tannapfel, Christian Wittekind. Pathologie. Pathologie 2020; : 565 doi: 10.1007/978-3-642-04557-8_17
|
| 16 |
Maria Diab, Philip A. Philip. Textbook of Gastrointestinal Oncology. 2019; : 197 doi: 10.1007/978-3-030-18890-0_12
|
| 17 |
David Escobar, Jessica Nguyen, Jennifer L. Pincus, Maryam Pezhouh. PD-L1 and CTLA-4 Expression and Prognostic Impact in Gallbladder Carcinoma. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4069590
|
| 18 |
Christine S. M. Lau, Aleksander Zywot, Krishnaraj Mahendraraj, Ronald S. Chamberlain. Gallbladder Carcinoma in the United States: A Population Based Clinical Outcomes Study Involving 22,343 Patients from the Surveillance, Epidemiology, and End Result Database (1973–2013). HPB Surgery 2017; 2017: 1 doi: 10.1155/2017/1532835
|
| 19 |
Amarpreet Bhalla, Steven A. Mann, Shaoxiong Chen, Oscar W. Cummings, Jingmei Lin. Histopathological evidence of neoplastic progression of von Meyenburg complex to intrahepatic cholangiocarcinoma. Human Pathology 2017; 67: 217 doi: 10.1016/j.humpath.2017.08.004
|
| 20 |
Ioan Cătălin Bodea, Andra Ciocan, Florin Vasile Zaharie, Raluca Bodea, Florin Graur, Ștefan Ursu, Răzvan Alexandru Ciocan, Nadim Al Hajjar. HER2 Overexpression in Periampullary Tumors According to Anatomical and Histological Classification—A Systematic Review. Journal of Personalized Medicine 2024; 14(5): 463 doi: 10.3390/jpm14050463
|
| 21 |
Nelson Yee. Update in Systemic and Targeted Therapies in Gastrointestinal Oncology. Biomedicines 2018; 6(1): 34 doi: 10.3390/biomedicines6010034
|
| 22 |
Lara P. Fernández, Marta Gómez de Cedrón, Ana Ramírez de Molina. Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.577420
|
| 23 |
Azfar Neyaz, Nuzhat Husain, Swati Kumari, Sameer Gupta, Saumya Shukla, Sanya Arshad, Nidhi Anand, Arun Chaturvedi. Clinical relevance of PD‐L1 expression in gallbladder cancer: a potential target for therapy. Histopathology 2018; 73(4): 622 doi: 10.1111/his.13669
|
| 24 |
Alessandro Rizzo, Giovanni Brandi. First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: “And Yet It Moves!”. Cancer Treatment and Research Communications 2021; 27: 100335 doi: 10.1016/j.ctarc.2021.100335
|
| 25 |
Sun‐ju Byeon, Mee Soo Chang, Hwa Jin Cho, Jeong Hwan Park, Ki Hwan Kim, Jin Hyun Park, In Sil Choi, Won Kim, Dong‐Seok Han, Hye Seong Ahn, Seung Chul Heo. Prognostic roles of leptin‐signaling proteins, PD‐L1, and tumor‐infiltrating lymphocytes in surgically‐resected biliary tract cancers. Journal of Surgical Oncology 2023; 127(4): 587 doi: 10.1002/jso.27140
|
| 26 |
Sahar Ahmadi Asouri, Esmat Aghadavood, Hamed Mirzaei, Alireza Abaspour, Mohammad Esmaeil Shahaboddin. PIWI-interacting RNAs (PiRNAs) as emerging biomarkers and therapeutic targets in biliary tract cancers: A comprehensive review. Heliyon 2024; 10(13): e33767 doi: 10.1016/j.heliyon.2024.e33767
|
| 27 |
Daniel Rojas-Sepúlveda, Andrés Tittarelli, María Alejandra Gleisner, Ignacio Ávalos, Cristián Pereda, Iván Gallegos, Fermín Eduardo González, Mercedes Natalia López, Jean Michel Butte, Juan Carlos Roa, Paula Fluxá, Flavio Salazar-Onfray. Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer. Cancer Immunology, Immunotherapy 2018; 67(12): 1897 doi: 10.1007/s00262-018-2157-5
|
| 28 |
Rebecca Allen, Naama Halpern, Sandra Algaze, Talia Golan, Anthony B. El-Khoueiry, Rachna T. Shroff. Moving Beyond Chemotherapy for Pancreaticobiliary Tumors: Targeted and Immunotherapy Strategies. American Society of Clinical Oncology Educational Book 2020; (40): e333 doi: 10.1200/EDBK_280901
|
| 29 |
Juthamas Yosudjai, Sopit Wongkham, Siwanon Jirawatnotai, Worasak Kaewkong. Aberrant mRNA splicing generates oncogenic RNA isoforms and contributes to the development and progression of cholangiocarcinoma (Review). Biomedical Reports 2019; doi: 10.3892/br.2019.1188
|
| 30 |
Xin Zhuang, Ya-ping Xiao, Ling-hua Tan, Lu-ting Wang, Qian Cao, Gui-fang Qu, Shuang Xiao, Hua-xin Duan. Efficacy and safety of chemotherapy with or without targeted therapy in biliary tract cancer: A meta-analysis of 7 randomized controlled trials. Journal of Huazhong University of Science and Technology [Medical Sciences] 2017; 37(2): 172 doi: 10.1007/s11596-017-1711-2
|
| 31 |
Angela Dalia Ricci, Alessandro Rizzo, Chiara Bonucci, Nastassja Tober, Andrea Palloni, Veronica Mollica, Ilaria Maggio, Marzia Deserti, Simona Tavolari, Giovanni Brandi. PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?. Medicines 2020; 7(9): 54 doi: 10.3390/medicines7090054
|
| 32 |
Mohammed Yousef Aldossary, Amal Ali Alayed, Samir S. Amr, Shareef Alqahtani, Mamdouh Alnahawi, Mohammed Saad Alqahtani. Gallbladder cancer in Eastern Province of Saudi Arabia: A retrospective cohort study. Annals of Medicine and Surgery 2018; 35: 117 doi: 10.1016/j.amsu.2018.09.020
|
| 33 |
Vivek K. Chaturvedi, Anshuman Singh, Sushil K. Dubey, Helal F. Hetta, James John, M.P. Singh. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma. Microbial Pathogenesis 2019; 128: 184 doi: 10.1016/j.micpath.2019.01.004
|
| 34 |
Nicola Fusco, Silvano Bosari. <i>HER2</i> aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists. World Journal of Gastroenterology 2016; 22(35): 7926-7937 doi: 10.3748/wjg.v22.i35.7926
|
| 35 |
Tsutomu Takenami, Shimpei Maeda, Hideaki Karasawa, Takashi Suzuki, Toru Furukawa, Takanori Morikawa, Tatsuyuki Takadate, Hiroki Hayashi, Kei Nakagawa, Fuyuhiko Motoi, Takeshi Naitoh, Michiaki Unno. Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5548-x
|
| 36 |
Kaichao Feng, Yang Liu, Yelei Guo, Jingdan Qiu, Zhiqiang Wu, Hanren Dai, Qingming Yang, Yao Wang, Weidong Han. Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers. Protein & Cell 2018; 9(10): 838 doi: 10.1007/s13238-017-0440-4
|
| 37 |
Gábor Lendvai, Tímea Szekerczés, Idikó Illyés, Réka Dóra, Endre Kontsek, Alíz Gógl, András Kiss, Klára Werling, Ilona Kovalszky, Zsuzsa Schaff, Katalin Borka. Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis. Pathology & Oncology Research 2020; 26(1): 3 doi: 10.1007/s12253-018-0491-8
|
| 38 |
Qingxin Zhou, Meihua Lin, Xing Feng, Fei Ma, Yuekun Zhu, Xing Liu, Chao Qu, Hong Sui, Bei Sun, Anlong Zhu, Heng Zhang, He Huang, Zhi Gao, Yongxiang Zhao, Jiangyun Sun, Yuxian Bai, Junfei Jin, Xuehui Hong, Chang Zou, Zhiyong Zhang. Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism. Journal of Experimental Medicine 2020; 217(8) doi: 10.1084/jem.20191779
|
| 39 |
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi. IDH inhibitors in advanced cholangiocarcinoma: Another arrow in the quiver?. Cancer Treatment and Research Communications 2021; 27: 100356 doi: 10.1016/j.ctarc.2021.100356
|
| 40 |
Ian Chau. Clinical Development of PD-1/PD-L1 Immunotherapy for Gastrointestinal Cancers: Facts and Hopes. Clinical Cancer Research 2017; 23(20): 6002 doi: 10.1158/1078-0432.CCR-17-0020
|
| 41 |
Jiwen Wang, Yanli Yao, Yue Ming, Sheng Shen, Nan Wu, Jiaqi Liu, Han Liu, Tao Suo, Hongtao Pan, Dexiang Zhang, Kan Ding, Houbao Liu. Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo. Scientific Reports 2016; 6(1) doi: 10.1038/srep28833
|
| 42 |
Yasushi Iinuma, Naoyuki Yokoyama, Nobuyuki Saikusa, Hideki Hashidate, Shin-ichi Naito, Yutaka Hirayama, Kengo Nakaya, Kohju Nitta. A long-term survivor after radical surgery in early childhood for biliary tract cancer associated with congenital biliary dilatation despite a positive margin for epithelial carcinoma. Journal of Pediatric Surgery Case Reports 2022; 79: 102211 doi: 10.1016/j.epsc.2022.102211
|
| 43 |
Anthony J. Scholer, Rebecca K. Marcus, Mary Garland-Kledzik, Debopriya Ghosh, Miquel Ensenyat-Mendez, Joshua Germany, Juan A. Santamaria-Barria, Adam Khader, Javier I. J. Orozco, Melanie Goldfarb. Exploring the Genomic Landscape of Hepatobiliary Cancers to Establish a Novel Molecular Classification System. Cancers 2024; 16(2): 325 doi: 10.3390/cancers16020325
|
| 44 |
Dustin E. Bosch, Matthew M. Yeh, Rodney A. Schmidt, Paul E. Swanson, Camtu D. Truong. Gallbladder carcinoma and epithelial dysplasia: Appropriate sampling for histopathology. Annals of Diagnostic Pathology 2018; 37: 7 doi: 10.1016/j.anndiagpath.2018.08.003
|